DNM1L and Alzheimer disease: Recent data show that Drp1 expression is significantly enhanced in the brain of AD patients and AD mice compared to healthy human controls and wild type mice, as well as Drp1 expression increases in neurons exposed to Aβ peptides in vitro (Medala et al., 2021; Bera et al., 2022).